Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Opus Genetics Inc (IRD)

Opus Genetics Inc (IRD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Opus Genetics Inc 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 USA

www.ocuphire.com Employees: 14 P: 248-957-9024

Description:

Opus Genetics Inc. is a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. Opus Genetics Inc., formerly known as Ocuphire Pharma Inc., is based in Farmington Hills, Michigan.

Key Statistics

Overview:

Market Capitalization, $K 31,884
Enterprise Value, $K -18,616
Shares Outstanding, K 31,568
Annual Sales, $ 19,050 K
Annual Net Income, $ -9,990 K
Last Quarter Sales, $ 3,870 K
Last Quarter Net Income, $ -7,530 K
EBIT, $ -29,480 K
EBITDA, $ -29,470 K
60-Month Beta 0.22
% of Insider Shareholders 6.60%
% of Institutional Shareholders 14.97%
Float, K 29,485
% Float 93.40%
Short Volume Ratio 0.24

Growth:

1-Year Return -64.06%
3-Year Return -76.78%
5-Year Return -85.40%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.82%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.29 on 11/12/24
Next Earnings Date 11/11/24
Earnings Per Share ttm -1.09
EPS Growth vs. Prev Qtr 3.33%
EPS Growth vs. Prev Year -216.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-4 on 11/06/20

IRD Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -63.64%
Return-on-Assets % -56.94%
Profit Margin % -52.44%
Debt/Equity 0.00
Price/Sales 1.63
Price/Cash Flow N/A
Price/Book 0.75
Book Value/Share 1.31
Interest Coverage -0.17
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar